VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here : IndiaNotes >> Research & Analysis >> Companies >> Take Solutions Ltd. >> Research

Take Solutions: Buy around at 143 for 15.40% upside in 3 months

SMC | 15 Dec, 2016  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 0.0 Based on 0 ratings)

According to the management of the company, it would grow at rate of 25 percent in organic segment in FY17 but also able to sustain similar growth for the next three years. On the margin front, margins for the lifescience business are upwards of 25 percent and that there is an opportunity to expand the margins by 1.5-2 percent over the next two years. Life science business of the company contributes over 75% to revenue and margin from SCM is 10-11% while it is nearly 22% from life sciences. Moreover, the company wants to become a specialized company in life sciences .

Business Profile

TAKE Solutions, is a globally recognized knowledge intensive technology player, delivering comprehensive and niche solutions for enterprises across diverse sectors for over 15 years, with key expertise in Life Sciences (LS) and Supply Chain Management (SCM). With its global headquarters in Chennai, India, it has a proven track record of delivering world-class solutions to more than 400 customers worldwide, including 9 of the top 10 global Pharma companies.

Investment Rationale

In the LS ( life science) domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and content management. In SCM (supply chain management), TAKE’s product suite includes distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking.

Its significant recognitions include a patent win from the United States Patent and Trademark Office (USPTO) for its ‘Method for Optimizing Clinical Data Standardization’, a ‘Leader’ certification in Drug Safety Services & Life Sciences R&D IT Outsourcing from IDC, recognition as the ‘Dream Employer of the Year’ at the World HRD Congress and the title of ‘Most Admired Brand –IT’ from the Asian Customer Engagement Forum.


On a consolidated basis, It has reported net profit of Rs 32.66 crore in Q2 Sep 2016 compared with net profit of Rs 25.05 crore in Q2 Sep 2016. Net sales rose 36% to Rs 328.35 crore in Q2 Sep 2016 over Q2 Sep 2015.

It has strong domain expertise in providing cost effective comprehensive solutions to the business. TSL provides LS solutions to pharmaceutical and biotechnology companies on a contract basis. The Life Sciences space is highly regulated by the USFDA and is subject to various laws and regulations such as HIPAA, ICH guidelines on Good Clinical Practices and other federal, state and local laws.


We recommend a buy in the stock of TAKE SOLUTIONS LTD for a short-term perspective. The stock is trading at its good support level with good fundamental records and is expected to move up from this level. It made a 52 week low Rs. 121.55 and 52 week high of Rs 189.30. Buy around at 143 with a closing below stop loss of Rs.129 levels for the target of Rs.165.

  Read full report Click here to read the full report

153.45 -2.25
154.30 -1.50
Read More
About SMC
SMC Research, founded in 1990, is India’s leading share and stock broker, provides a wide range of financial services and investment solutions. A blend of extensive experience, diverse talent and client focus has made us the 4th largest broking house in India(Source: Dun and Bradstreet, 2008). Over the years, SMC has expanded its operations domestically as well as internationally. Existing network includes regional offices at Mumbai, Kolkata, Chennai, Cochin, Ahmedabad, Jaipur, Hyderabad, Bangalore plus a growing network of 2100+ offices spread across 425 cities/towns in India.

For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor accept any liability whatsoever arising from the use of any of the above contents.

Technical Calls

What are technical calls?

Other Articles

Have a question?

Investment Advisory Company - Financial Market Research and Consulting